Stifel Financial Corp Neurocrine Biosciences Inc Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Stifel Financial Corp holds 18,251 shares of NBIX stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,251
Previous 18,167 0.46%
Holding current value
$2.69 Million
Previous $2.5 Million 15.99%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $9,624 - $12,864
84 Added 0.46%
18,251 $2.1 Million
Q2 2024

Aug 13, 2024
SELL
$130.86 - $143.19 $124,447 - $136,173
-951 Reduced 4.97%
18,167 $2.5 Million
Q1 2024

May 13, 2024
BUY
$130.4 - $143.74 $97,669 - $107,661
749 Added 4.08%
19,118 $2.64 Million
Q4 2023

Feb 12, 2024
SELL
$106.07 - $132.76 $45,079 - $56,422
-425 Reduced 2.26%
18,369 $2.42 Million
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $357,464 - $445,214
3,802 Added 25.36%
18,794 $2.11 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $52,554 - $61,558
-587 Reduced 3.77%
14,992 $1.41 Million
Q1 2023

May 12, 2023
SELL
$94.11 - $123.02 $13,363 - $17,468
-142 Reduced 0.9%
15,579 $1.58 Million
Q4 2022

Feb 13, 2023
SELL
$106.72 - $127.06 $186,333 - $221,846
-1,746 Reduced 10.0%
15,721 $1.88 Million
Q3 2022

Nov 14, 2022
SELL
$92.03 - $107.81 $138,321 - $162,038
-1,503 Reduced 7.92%
17,467 $1.86 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $398,579 - $526,268
-5,259 Reduced 21.71%
18,970 $1.85 Million
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $168,518 - $220,528
-2,326 Reduced 8.76%
24,229 $2.27 Million
Q4 2021

Feb 14, 2022
SELL
$79.65 - $106.22 $527,203 - $703,070
-6,619 Reduced 19.95%
26,555 $2.26 Million
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $245,009 - $281,542
-2,843 Reduced 7.89%
33,174 $3.18 Million
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $371,671 - $425,034
4,156 Added 13.04%
36,017 $3.51 Million
Q1 2021

May 14, 2021
BUY
$87.57 - $119.4 $78,462 - $106,982
896 Added 2.89%
31,861 $3.1 Million
Q4 2020

Feb 12, 2021
BUY
$86.91 - $108.33 $222,837 - $277,758
2,564 Added 9.03%
30,965 $2.97 Million
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $490,800 - $689,805
5,104 Added 21.91%
28,401 $2.73 Million
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $307,174 - $470,599
3,610 Added 18.34%
23,297 $2.84 Million
Q1 2020

May 14, 2020
SELL
$75.11 - $113.76 $218,870 - $331,496
-2,914 Reduced 12.89%
19,687 $1.72 Million
Q4 2019

Feb 13, 2020
BUY
$86.8 - $118.57 $630,168 - $860,818
7,260 Added 47.32%
22,601 $2.43 Million
Q3 2019

Nov 19, 2019
BUY
$83.82 - $101.5 $1,341 - $1,624
16 Added 0.1%
15,341 $1.4 Million
Q3 2019

Nov 13, 2019
BUY
$83.82 - $101.5 $651,868 - $789,365
7,777 Added 103.03%
15,325 $1.39 Million
Q2 2019

Aug 14, 2019
BUY
$72.24 - $91.27 $268,371 - $339,068
3,715 Added 96.92%
7,548 $643,000
Q1 2019

May 14, 2019
BUY
$69.31 - $91.53 $265,665 - $350,834
3,833 New
3,833 $344,000
Q4 2018

Feb 13, 2019
SELL
$68.32 - $124.36 $211,928 - $385,764
-3,102 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$98.88 - $125.85 $306,725 - $390,386
3,102 New
3,102 $383,000
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $235,817 - $312,610
-4,029 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$47.97 - $61.28 $193,271 - $246,897
4,029
4,029 $0

Others Institutions Holding NBIX

# of Institutions
635
Shares Held
93.5M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email